Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share

Market Share of Focal Segmental Glomerulosclerosis (FSGS) Treatment Industry

The focal segmental glomerulosclerosis (FSGS) treatment market is consolidated due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including B. Braun Melsungen AG, Beckman Coulter Inc., Baxter International Inc., ChemoCentryx Inc., Complexa Inc., and Pfizer Inc., among others.

Focal Segmental Glomerulosclerosis Treatment Market Leaders

1. B. Braun Melsungen AG

2. Beckman Coulter Inc. (Danaher Corporation)

3. Medtronic Plc

4. Retrophin Inc.

5. Complexa Inc.

*Disclaimer: Major Players sorted in no particular order